NHS national Generic Pharmaceuticals Transition 2021_2

A Tender Notice
by THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)

Source
Find a Tender
Type
Framework (Supply)
Duration
19.5 month
Value
116M
Sector
HEALTH
Published
19 Jan 2021
Delivery
15 Jun 2021 to 31 Jan 2023
Deadline
23 Feb 2021 13:00

Concepts

Location

Please refer to document 03, schedule 8 in the ITO documents for the list of Purchasing Points

Geochart for 2 buyers and 0 suppliers

Description

Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months)

Lot Division

1 CM/PHG/20/5631/00 Transition Products - CESW Region
  • Duration: 12.5 month

Invitation to offer for NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number: Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products:

2 CM/PHG/20/5631/00 Transition Products - LSNE Region
  • Duration: 19.5 month

Invitation to offer for NHS National Pharmaceuticals Transition 2021_2 Offer reference number: CM/PHG/20/5631 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months) OJEU Reference number: Potential periods of call-offs under the framework agreement: Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months) Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months) LSNE: 15/06/2021 to 31/01/2023 (19.5 months) NWLN: 15/06/2021 to 31/01/2022 (7.5 months) Hospital Only Housekeeping Products:

3 CM/PHG/20/5631/00 Transition Products - NWLN Region
  • Duration: 7.5 month

Invitation to offer for NHS National Pharmaceuticals Transition 2021_2 Offer reference number: CM/PHG/20/5631 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months) OJEU Reference number: Potential periods of call-offs under the framework agreement: Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months) Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months) LSNE: 15/06/2021 to 31/01/2023 (19.5 months) NWLN: 15/06/2021 to 31/01/2022 (7.5 months) Hospital Only Housekeeping Products:

4 CM/PHG/20/5631/01 - Oral (plus non-parenteral) Products - All Regions
  • Duration: 8.5 month

Invitation to offer for NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number: Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products:

5 CM/PHG/20/5631/02 - Hospital Only/Housekeeping - DLS/DNE/DNW Regions
  • Duration: 7.5 month

Invitation to offer for NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number: Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products:

6 CM/PHG/20/5631/02 - Hospital Only/Housekeeping - DLN/DCE/DSW Regions
  • Duration: 7.5 month

Invitation to offer for NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number: Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products:

CPV Codes

  • 33600000 - Pharmaceutical products
  • 33690000 - Various medicinal products

Indicators

  • Bids should cover one or more lots.
  • Bids should cover the whole contract.
  • Options are available.
  • Renewals are not available.
  • Performance considerations apply.
  • Award on basis of price and quality.

Other Information

RESPONDING TO THIS NOTICE; Any supplier may be disqualified who does not respond to the following in the requisite manner: 1) Submission of expression of interest and procurement specific information. This procurement exercise will be conducted on the eTendering portal at http://health.atamis.co.uk Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested) through the eTendering portal as follows: 1.1) If not already registered, Candidates should register on the eTendering portal at http://health.atamis.co.uk and click the link to register: - agree to the user agreement - populate company details 1.2) Once registered, candidates must register interest as follows: - log to the portal - select "Find Opportunities" from the supplier home screen, use the "Sort by:" facility to find this opportunity and select the bold blue title to select - review opportunity details and click "Register Interest" - as you select the opportunity, you can review documents, send clarification messages, submit the response or decline to respond (if you decide not to participate in the opportunity) 1.3) There is a supplier user guide on using the system and Candidates can contact the Atamis helpdesk at supporthealth@atamis.co.uk or by calling 0800 9956035 for technical assistance when completing responses. 2) General supplier information. To manage and assess supplier information the Contracting Authority requests candidates provide their company profile in the Government's Supplier Registration Service (which has replaced sid4gov), as follows: 2.1) If not already registered (the previous sid4gov password, login and details will still be on the system), candidates must go to the following web page https://supplierregistration.cabinetoffice.gov.uk and select "Register" at the top of the page. Key in details as requested to search for your company. If you do not have a D-U-N-S® Number, click on the link at the right of the page to obtain a number from DB. Candidates must obtain a Dun Bradstreet (DB) D-U-N-S® Number to enable registration on the system. 2.2) Once registration is complete you are able to create and update your company profile. Candidates should ensure all the mandatory fields of their profile are completed and up to date for each procurement exercise. DB data will be supplied automatically by DB. 2.3) For further help or information concerning this telephone +44 (0) 161 413 7982 or via the message function on the website. OTHER CONTRACTING AUTHORITIES The framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services.

Reference

Domains